📰 Bioscience Price News
Bioscience Price News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioscience Price. Real-time updates on events, politics, business and more.
May 5, 2024
HC Wainwright reiterated their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $6.00 price objective on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the stock. Dawson James downgraded shares of Daré […]
November 30, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.42 and traded as low as $0.33. Daré Bioscience shares last traded at $0.34, with a volume of 233,070 shares changing hands. Analysts Set New Price […]
September 19, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 836,800 shares, a growth of 19.4% from the August 15th total of 700,900 shares. Based on an average daily volume of 307,200 shares, […]
June 10, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – Brookline Capital Management issued their Q3 2023 earnings estimates for Daré Bioscience in a report released on Monday, June 5th. Brookline Capital Management analyst K. Dolliver expects that the biotechnology company will earn ($0.07) per share for the quarter. Brookline Capital Management currently has a “Buy” rating […]
May 28, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 378,600 shares, a decrease of 25.9% from the April 30th total of 511,000 shares. Based on an average daily volume of 191,300 shares, the […]
May 3, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 612,400 shares, an increase of 12.5% from the March 31st total of 544,400 shares. Based on an average daily trading volume, of 283,800 shares, […]
April 3, 2023
HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other equities research analysts […]
April 2, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 466,000 shares, a drop of 15.9% from the February 28th total of 554,100 shares. Based on an average trading volume of 320,500 shares, the days-to-cover ratio is […]
April 1, 2023
HC Wainwright reaffirmed their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. They currently have a $7.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other research firms have also […]